← Back to Search

Phototherapy

Phototherapy (NB-UVB) via the 3 Series PC & SP phototherapy cabinet for Vitiligo

N/A
Waitlist Available
Led By Noori Kim, M.D
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights

Study Summary

This trial is looking at the effects of Narrow band UVB (NB-UVB) treatment on protein expression and histological changes in skin from participants with Vitiligo.

Eligible Conditions
  • Vitiligo
  • Skin Conditions

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Molecular Changes From NB-UVB Therapy

Trial Design

1Treatment groups
Experimental Treatment
Group I: Phototherapy (NB-UVB)Experimental Treatment1 Intervention
Phototherapy (NB-UVB) will be administered for all enrolled subjects. The starting dosage will be 250 mJ/cm2. The dose will be increased by 10% with each treatment, as long as there are no side effects with treatment.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Phototherapy (NB-UVB) via the 3 Series PC & SP phototherapy cabinet
2017
N/A
~10

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,242 Previous Clinical Trials
14,816,627 Total Patients Enrolled
1 Trials studying Vitiligo
2 Patients Enrolled for Vitiligo
Noori Kim, M.DPrincipal InvestigatorJohns Hopkins University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are additional volunteers being sought for this experiment?

"According to the records on clinicaltrials.gov, this investigation is no longer recruiting patients; its initial posting was October 1st 2017 and its last update June 28th 2022. However, there are currently 37 other trials that still require participants."

Answered by AI

Is this study open to those over the age of 55 years?

"This medical trial is open to adults aged 18-100. For those younger than 18 and older than 65, there are 8 trials and 34 trials respectively available for them to consider."

Answered by AI

To whom is this clinical trial open for enrollment?

"This trial, which seeks to enroll 20 individuals affected by vitiligo aged between 18 and 100 years old, requires applicants to understand the consent procedure and be able to adhere with protocol activities."

Answered by AI

Who else is applying?

What state do they live in?
District of Columbia
Virginia
Tennessee
How old are they?
18 - 65
What site did they apply to?
Johns Hopkins Outpatient Center
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0
1

Why did patients apply to this trial?

I’ve had vitiligo at three separate times in my life. This third time has been the worst in teams of how much surface area has lost pigment.
PatientReceived no prior treatments
~1 spots leftby Mar 2025